PIB: A score to select sorafenib treatment candidates for hepatocellular carcinoma in resource-limited settings

Article

Abstract:

Palabras claves:

HCC, hepatocellular carcinoma, SCORE, Sorafenib

Autores:

Balderramo D., Barreyro F.J., Carrilho F.J., Debes J.D., Diaz-Ferrer J., Diehl F., Enrique Carrera, Ferreiro M.R., Gonzalez-Ballerga E., Leathers J.S., Mattos A.Z., Prieto J.E., Singh D.

Fuentes:

scopus